Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 304 followers
Latest posts
Last updated 2 days ago
IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants
2 days ago
IRIS guide for applicants - How to create, submit and manage IRIS...
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation: 14/08/2025, Revision: 3, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 2, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Revision: 1, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Revision: 1...
Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 4, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation...
Human medicines European public assessment report (EPAR): Praluent, alirocumab, Date of authorisation: 23/09/2015, Revision: 26, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Praluent, alirocumab, Date of authorisation...
Healthcare Professionals' Working Party (HCPWP) plenary meeting February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, 3 February 2026
3 days ago
Healthcare Professionals' Working Party (HCPWP) plenary meeting February 2026, Online, European Medicines...
Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation: 24/09/2020, Revision: 11, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn
3 days ago
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 14, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation...
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 51, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Date of authorisation: 17/11/2014, Revision: 29, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Date of authorisation...